Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings
The Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time (TAT) in Emergency Settings
1 other identifier
observational
136
1 country
1
Brief Summary
This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2025
CompletedStudy Start
First participant enrolled
August 23, 2025
CompletedFirst Posted
Study publicly available on registry
August 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 26, 2025
August 1, 2025
1.3 years
August 17, 2025
August 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity of magnetic resonance imaging for acute stroke
Sensitivity of magnetic resonance imaging for acute stroke will be recorded.
Immediately post-procedure (Up to 1 hour)
Study Arms (1)
Study group
Patients with acute stroke who are admitted to the emergency department.
Interventions
Magnetic Resonance Imaging will be performed to all patients
Eligibility Criteria
This prospective cohort study will be carried out on 136 patients presenting with acute stroke symptoms after approval from the institutional ethical committee.
You may qualify if:
- Age ≥18 years.
- Both sexes.
- Patients with acute stroke who are admitted to the emergency department.
You may not qualify if:
- Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT).
- Symptoms strongly suggestive of subarachnoid hemorrhage.
- Initiation of antithrombotic or thrombolytic treatment before the completion of both scans.
- Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms.
- Uncontrollable hypertension.
- Pregnant or lactating women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, El-Gharbia, 31527, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Emergency Medicine and Trauma, Faculty of Medicine, Tanta University, Tanta, Egypt.
Study Record Dates
First Submitted
August 17, 2025
First Posted
August 24, 2025
Study Start
August 23, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 26, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.